Hay fever medications: which are permitted?
In light of the recent rise in pollen levels, UK Anti-Doping (UKAD) has today published a useful guide on the anti-doping status of common hay fever medications according to the 2019 World Anti-Doping Agency (WADA) Prohibited List.
Many over-the-counter products containing the ingredients listed below are permitted medications. However, several medical treatments for hay fever appear on the WADA Prohibited List as being prohibited in-competition.
Therefore, UKAD reminds athletes to check the status of their medications using the Global Drug Reference Online (Global DRO) website.
Permitted hay fever medications:
• Antihistamine tablets (acrivastine, cetirizine, fexofenadine, loratadine)
• Eye drops (sodium cromoglicate)
• Nasal sprays and drops
o Glucocorticoid nasal sprays (beclometasone, betamethasone, budesonide, fluticasone)
o Antihistamine nasal spray (azelastine)
o Nasal drops (xylometazoline)
Hay fever medications prohibited in-competition:
• Intramuscular triamcinolone injection – refer to the UKAD hay fever guidelines document below
• Prednisolone tablets – requires a TUE, contact UKAD
• Decongestant tablets containing pseudoephedrine (PSE) – refer to the Prohibited List Q&A section of the WADA website